The McGill Biotechnology Graduate Students Society will be holding its sixth annual BioConnect symposium this year under the theme “From Bench to Bedside” to explore the practical applications of biotechnology research, as well as the importance of complementary fields such as commercialization, marketing, intellectual property, and more!
Last year's event, “Stimulating Innovation Through Collaboration”, focused on the collaboration between academia and industry in the biotechnology community, and attracted more than 150 participants from both industry and the university milieu (McGill and other universities) as well as an impressive lineup of speakers from the financial, regulatory, scientific, and McGill communities.
This year’s event will take place on November 18th, 2016 at McGill University's New Residence Hall and will include presentations by invited experts in various biotechnology-related fields, an in-depth panel discussion, a poster presentation competition, and a networking cocktail held in partnership with BiotechAnnecto. We extend our invitation to the interdisciplinary biotechnology community that wishes to learn about and discuss the challenges that the Canadian Biotech industry is currently facing, with an emphasis on innovation, collaboration, and application.
BioConnect's Featured Start-up Company
inSynergy BioPharmaceutics Inc.
inSynergy BioPharmaceutics is a Clinical Pharmacology Unit located in Montreal, due to operate by early 2017, and conducting Bioequivalence and early-stage clinical development. It has the expertise to assess small and large molecules, in most therapeutic areas and in most routes of administration. It offers the high standards of quality and Phase I EDC solutions, ensuring successful audits and inspections.